Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB Notes Newsletter

(PDF - 1.7 MB)

No. 4, 2013

In This Issue

Director's Letter

Highlights from State and Local Programs

Bedaquiline, a New Drug for MDR TB

NTCA Responds to the Shortages of TB Drugs and Diagnostics

TB Education and Training Network Updates

TB Epidemiologic Studies Consortium Updates

Communications, Education, and Behavioral Studies Branch Updates

International Research and Programs Branch Updates


Laboratory Branch Updates

New CDC Publications

Personnel Notes

Calendar of Events

Note: The use of trade names in this publication is for identification purposes only and does not imply endorsement by the Centers for Disease Control and Prevention (CDC), the Public Health Service, or the Department of Health and Human Services. The findings and conclusions in the articles published in TB Notes are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30329
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO
  • Page last reviewed: December 23, 2013
  • Page last updated: September 24, 2014 The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO